Dranitzki-Elhalel, M <br/><br/>
CD40.FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism.  [electronic resource] 

 -  International immunology  Apr 2007 
 - 355-63 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0953-8178 
<br/><br/><label>Standard No.: </label>10.1093/intimm/dxm001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Apoptosis--drug effects<br/>B-Lymphocytes--cytology<br/>CD3 Complex--immunology<br/>CD40 Antigens--genetics<br/>CD40 Ligand--genetics<br/>CD8 Antigens--genetics<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Coculture Techniques<br/>Dose-Response Relationship, Drug<br/>Fas Ligand Protein--genetics<br/>Humans<br/>Jurkat Cells<br/>Leukocytes, Mononuclear--cytology<br/>Lymphocyte Activation--drug effects<br/>Mice<br/>NIH 3T3 Cells<br/>Protein Binding--drug effects<br/>Recombinant Fusion Proteins--metabolism<br/>T-Lymphocytes--cytology<br/>Transfection<br/>fas Receptor--metabolism